takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
William W. Chin M.D.
Member of Takeda Global Advisory Board, Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 69 board members in 5 different organizations across 7 different industries.|
See Board Relationships
Dr. William W. Chin, M.D. serves as an Executive Dean of Research, Bertarelli Professor for Translational Medical Science and Professor of Medicine at Harvard Medical School (HMS). Dr. Chin served as Senior Vice President of Discovery & Clinical Research at Eli Lilly and Company. Dr. Chin served as the Vice President of Discovery Biology Research and Clinical Investigation of Eli Lilly and Company since July 2003. He served as Vice President of gene regulation, bone ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Vincent A. Forlenza BD||Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Becton, Dickinson and Company
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Herve Hoppenot||Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee|
|Karl-Ludwig Kley||Chairman of Executive Board and Chief Executive Officer|
|€6.6M||Compensation as of Fiscal Year 2014.|